Johnson Health Tech Co Ltd (1736) - Net Assets
Based on the latest financial reports, Johnson Health Tech Co Ltd (1736) has net assets worth NT$11.32 Billion TWD (≈ $356.62 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$44.55 Billion ≈ $1.40 Billion USD) and total liabilities (NT$33.23 Billion ≈ $1.05 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 1736 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$11.32 Billion |
| % of Total Assets | 25.41% |
| Annual Growth Rate | 10.3% |
| 5-Year Change | 17.15% |
| 10-Year Change | 35.18% |
| Growth Volatility | 16.88 |
Johnson Health Tech Co Ltd - Net Assets Trend (2002–2024)
This chart illustrates how Johnson Health Tech Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Johnson Health Tech Co Ltd total assets for the complete picture of this company's asset base.
Annual Net Assets for Johnson Health Tech Co Ltd (2002–2024)
The table below shows the annual net assets of Johnson Health Tech Co Ltd from 2002 to 2024. For live valuation and market cap data, see Johnson Health Tech Co Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$12.04 Billion ≈ $379.47 Million |
+24.82% |
| 2023-12-31 | NT$9.65 Billion ≈ $304.01 Million |
+1.76% |
| 2022-12-31 | NT$9.48 Billion ≈ $298.74 Million |
+1.08% |
| 2021-12-31 | NT$9.38 Billion ≈ $295.56 Million |
-8.76% |
| 2020-12-31 | NT$10.28 Billion ≈ $323.93 Million |
+12.53% |
| 2019-12-31 | NT$9.14 Billion ≈ $287.87 Million |
+8.38% |
| 2018-12-31 | NT$8.43 Billion ≈ $265.61 Million |
+3.22% |
| 2017-12-31 | NT$8.17 Billion ≈ $257.32 Million |
-5.09% |
| 2016-12-31 | NT$8.61 Billion ≈ $271.12 Million |
-3.42% |
| 2015-12-31 | NT$8.91 Billion ≈ $280.71 Million |
-2.09% |
| 2014-12-31 | NT$9.10 Billion ≈ $286.71 Million |
+35.61% |
| 2013-12-31 | NT$6.71 Billion ≈ $211.43 Million |
+13.95% |
| 2012-12-31 | NT$5.89 Billion ≈ $185.55 Million |
+4.98% |
| 2011-12-31 | NT$5.61 Billion ≈ $176.74 Million |
+19.53% |
| 2010-12-31 | NT$4.69 Billion ≈ $147.86 Million |
-2.70% |
| 2009-12-31 | NT$4.82 Billion ≈ $151.96 Million |
-4.19% |
| 2008-12-31 | NT$5.03 Billion ≈ $158.61 Million |
-3.91% |
| 2007-12-31 | NT$5.24 Billion ≈ $165.06 Million |
+1.64% |
| 2006-12-31 | NT$5.15 Billion ≈ $162.40 Million |
+43.35% |
| 2005-12-31 | NT$3.60 Billion ≈ $113.29 Million |
+48.91% |
| 2004-12-31 | NT$2.41 Billion ≈ $76.08 Million |
+29.43% |
| 2003-12-31 | NT$1.87 Billion ≈ $58.78 Million |
+33.85% |
| 2002-12-31 | NT$1.39 Billion ≈ $43.91 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Johnson Health Tech Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1671.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$10.32 Billion | 85.76% |
| Common Stock | NT$3.03 Billion | 25.20% |
| Other Comprehensive Income | NT$-1.75 Billion | -14.54% |
| Other Components | NT$430.29 Million | 3.57% |
| Total Equity | NT$12.04 Billion | 100.00% |
Johnson Health Tech Co Ltd Competitors by Market Cap
The table below lists competitors of Johnson Health Tech Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHINA RISUN GROUP HD-10
F:45Y
|
$1.17 Billion |
|
Trinity Capital Inc
NASDAQ:TRIN
|
$1.17 Billion |
|
Shanghai Tongji Science&Technology Industrial Co Ltd
SHG:600846
|
$1.17 Billion |
|
Lindsay Corporation
NYSE:LNN
|
$1.17 Billion |
|
Shenyang Toly Bread Co Ltd
SHG:603866
|
$1.17 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
$1.17 Billion |
|
Shenzhen Farben Information Technology Co.Ltd.
SHE:300925
|
$1.16 Billion |
|
Vizsla Silver Corp.
TO:VZLA
|
$1.16 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Johnson Health Tech Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 9,642,572,000 to 12,037,344,000, a change of 2,394,772,000 (24.8%).
- Net income of 2,430,180,000 contributed positively to equity growth.
- Dividend payments of 302,922,000 reduced retained earnings.
- New share issuances of 30,126,000 increased equity.
- Other comprehensive income increased equity by 228,757,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$2.43 Billion | +20.19% |
| Dividends Paid | NT$302.92 Million | -2.52% |
| Share Issuances | NT$30.13 Million | +0.25% |
| Other Comprehensive Income | NT$228.76 Million | +1.9% |
| Other Changes | NT$8.63 Million | +0.07% |
| Total Change | NT$- | 24.84% |
Book Value vs Market Value Analysis
This analysis compares Johnson Health Tech Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.07x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.34x to 3.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | NT$16.62 | NT$122.00 | x |
| 2007-12-31 | NT$17.09 | NT$122.00 | x |
| 2008-12-31 | NT$16.53 | NT$122.00 | x |
| 2009-12-31 | NT$15.82 | NT$122.00 | x |
| 2010-12-31 | NT$15.43 | NT$122.00 | x |
| 2011-12-31 | NT$18.45 | NT$122.00 | x |
| 2012-12-31 | NT$19.36 | NT$122.00 | x |
| 2013-12-31 | NT$22.08 | NT$122.00 | x |
| 2014-12-31 | NT$29.92 | NT$122.00 | x |
| 2015-12-31 | NT$29.28 | NT$122.00 | x |
| 2016-12-31 | NT$28.33 | NT$122.00 | x |
| 2017-12-31 | NT$26.93 | NT$122.00 | x |
| 2018-12-31 | NT$27.79 | NT$122.00 | x |
| 2019-12-31 | NT$30.11 | NT$122.00 | x |
| 2020-12-31 | NT$30.88 | NT$122.00 | x |
| 2021-12-31 | NT$28.02 | NT$122.00 | x |
| 2022-12-31 | NT$31.31 | NT$122.00 | x |
| 2023-12-31 | NT$31.83 | NT$122.00 | x |
| 2024-12-31 | NT$39.69 | NT$122.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Johnson Health Tech Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.19%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.09%
- • Asset Turnover: 1.10x
- • Equity Multiplier: 3.62x
- Recent ROE (20.19%) is above the historical average (13.98%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 32.86% | 12.49% | 1.02x | 2.57x | NT$318.57 Million |
| 2003 | 30.80% | 11.80% | 1.08x | 2.42x | NT$387.98 Million |
| 2004 | 31.37% | 11.30% | 1.20x | 2.31x | NT$516.03 Million |
| 2005 | 34.31% | 14.45% | 1.21x | 1.96x | NT$874.24 Million |
| 2006 | 33.91% | 15.07% | 1.18x | 1.91x | NT$1.20 Billion |
| 2007 | 10.81% | 4.74% | 1.07x | 2.13x | NT$41.80 Million |
| 2008 | 0.05% | 0.02% | 1.10x | 2.18x | NT$-499.13 Million |
| 2009 | -1.37% | -0.65% | 0.97x | 2.18x | NT$-545.28 Million |
| 2010 | 5.35% | 2.13% | 1.13x | 2.21x | NT$-217.66 Million |
| 2011 | 13.76% | 5.65% | 1.06x | 2.30x | NT$210.69 Million |
| 2012 | 14.58% | 5.60% | 1.08x | 2.40x | NT$269.43 Million |
| 2013 | 12.78% | 5.69% | 1.02x | 2.21x | NT$186.23 Million |
| 2014 | 29.00% | 15.94% | 0.82x | 2.21x | NT$1.73 Billion |
| 2015 | 6.33% | 3.32% | 0.76x | 2.51x | NT$-326.94 Million |
| 2016 | 8.33% | 3.55% | 0.89x | 2.64x | NT$-143.91 Million |
| 2017 | 1.59% | 0.67% | 0.88x | 2.73x | NT$-686.05 Million |
| 2018 | 4.63% | 1.79% | 0.92x | 2.82x | NT$-452.68 Million |
| 2019 | 14.16% | 5.09% | 0.94x | 2.95x | NT$379.55 Million |
| 2020 | 7.27% | 2.39% | 0.91x | 3.34x | NT$-255.27 Million |
| 2021 | 1.17% | 0.32% | 0.87x | 4.16x | NT$-748.61 Million |
| 2022 | 2.37% | 0.67% | 0.86x | 4.10x | NT$-722.56 Million |
| 2023 | 7.36% | 1.86% | 1.05x | 3.78x | NT$-254.43 Million |
| 2024 | 20.19% | 5.09% | 1.10x | 3.62x | NT$1.23 Billion |
Industry Comparison
This section compares Johnson Health Tech Co Ltd's net assets metrics with peer companies in the Leisure industry.
Industry Context
- Industry: Leisure
- Average net assets among peers: $2,750,021,556
- Average return on equity (ROE) among peers: 2.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Johnson Health Tech Co Ltd (1736) | NT$11.32 Billion | 32.86% | 2.94x | $1.17 Billion |
| Trk Corp (1432) | $799.85 Million | 0.00% | 4.58x | $57.33 Million |
| Rexon Industrial Corp Ltd (1515) | $2.96 Billion | 0.00% | 1.40x | $125.21 Million |
| Sun Race Sturmey-Archer Inc (1526) | $602.98 Million | 12.05% | 1.17x | $30.91 Million |
| Chi Hua Fitness Co Ltd (1593) | $794.85 Million | 12.58% | 0.28x | $39.23 Million |
| Dyaco International Inc (1598) | $4.95 Billion | 1.45% | 1.25x | $108.99 Million |
| Topkey Corp (4536) | $5.99 Billion | 13.88% | 0.88x | $427.77 Million |
| Brogent Technologies (5263) | $2.81 Billion | 9.47% | 0.24x | $207.84 Million |
| Janfusun Fancyworld (5701) | $764.15 Million | -25.17% | 3.07x | $15.36 Million |
| Fusheng Precision Co Ltd (6670) | $5.08 Billion | 0.00% | 1.45x | $1.10 Billion |
About Johnson Health Tech Co Ltd
Johnson Health Tech .Co., Ltd. engages in the manufacture and sale of sports and fitness equipment in the Americas, Europe, Asia, and internationally. It offers cardiopulmonary resuscitation and weight training equipment, and related electronic components, as well as video transmission and streaming service; researches, develops, manufactures, and trades in massage chairs; and sells food products… Read more